Skip to Main Content

Investigative Medicine Program

Representative Publications

Lemaire M, Frémeaux-Bacchi V, Schaefer F, Choi M, Tang WH, Le Quintrec M, Fakhouri F, Taque S, Nobili F, Martinez F, Ji W, Overton JD, Mane SM, Nürnberg G, Altmüller J, Thiele H, Morin D, Deschenes G, Baudouin V, Llanas B, Collard L, Majid MA, Simkova E, Nürnberg P, Rioux-Leclerc N, Moeckel GW, Gubler MC, Hwa J, Loirat C, Lifton RP. Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome. 2013. Nat Genet. May;45(5):531-6. PMCID: PMC3719402

Samuel VT, Beddow SA, Iwasaki T, Zhang XM, Chu X, Still CD, Gerhard GS, Shulman GI. Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes. 2009. Proc Natl Acad Sci U S A. Jul 21;106(29):12121-6. PMCID: PMC2707270

Tang PC, Qin L, Zielonka J, Zhou J, Matte-Martone C, Bergaya S, van Rooijen N, Shlomchik WD, Min W, Sessa WC, Pober JS, Tellides G. MyD88-dependent, superoxide-initiated inflammation is necessary for flow-mediated inward remodeling of conduit arteries. 2008. J Exp Med. Dec 22;205(13):3159-71. PMCID: PMC2605224

Miller EJ, Li J, Leng L, McDonald C, Atsumi, T, Bucala R, Young LH. Macrophage migration inhibitory factor sitmulates AMP-activated protein kinase in the ischemic heart. 2008. Nature. Jan 31;451(7178):578-82.

Das R, Koo MS, Kim BH, Jacob ST, Subbian S, Yao J, Leng L, Levy R, Murchison C, Burman WJ, Moore CC, Scheld WM, David JR, Kaplan G, MacMicking JD, Bucala R. Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis. 2013. Proc Natl Acad Sci U S A. Aug 6;110(32):E2997-3006. PMCID: PMC3740876

Click here for more information about the Investigative Medicine Program.